Stocks TelegraphStocks Telegraph
Stock Ideas

OVID Stock Performance and Key Statistics

NASDAQ : OVID

Ovid Therapeutics

$1.60
0.15+10.34%
At Close 4:00 PM
57.48
BESG ScoreESG Rating

stock performance chart

OVID Fundamental Analysis

Based on recent data, Ovid Therapeutics Inc. (OVID) shows an Average True Range (ATR) of 0.12 and an Enterprise Value of 241.7M. Its average trading volume over the past 3 months is 1.62M, indicating liquidity. These fundamental metrics provide insight into OVID's underlying financial health and market activity.

ATR0.12
Enterprise Value241.7M
Avg Vol (3 Months)1.62M
Avg Vol (10 Days)1.8M

OVID Technical Analysis Indicators

Ovid Therapeutics Inc. (OVID) technical indicators as of February 7, 2026: the SMA 20 is -0.44%, SMA 50 at -1.84%, and SMA 200 at 52.92%. The RSI 14 value is 49.97, suggesting its current momentum. These technical analysis signals help assess OVID's price trends and potential future movements.

SMA 20-0.44%
SMA 50-1.84%
SMA 20052.92%
RSI 1449.97

OVID Stock Performance Overview

Ovid Therapeutics Inc. (OVID) stock performance overview as of February 7, 2026: The 52-week high is $2.01 (currently -20.4% below), and the 52-week low is $0.243 (currently 559.79% above). Over the past year, OVID's performance is 108.22%, compared to the S&P 500's 8.57% change.

52-Week High2.01
52-Week High Chg-20.40%
52-Week Low0.2425
52-Week Low Chg+559.79%
S&P 500 52-Week Chg8.57%

Ovid Therapeutics Inc. (OVID) Historical Stock Performance

According to market data, Ovid Therapeutics Inc. (OVID) stock's recent performance metrics show that over the last month, OVID is 2.7%, with a Year-to-Date (YTD) performance of -6.75%. Over the past year, the stock has seen a 108.22% change. These figures summarize OVID's price movements across various periods, reflecting its historical returns.

Period1 Week1 MonthQuarterHalf Year1 YearYTD
High1.611.871.882.012.011.87
Low1.41.41.180.50.24251.4
Performance-5.59%+2.70%+2.70%+151.07%+108.22%-6.75%

Industry Analysis and Valuation

According to current financial data, OVID stock's P/E (TTM) ratio is -3.06, which compares to the S&P 500's P/E of 32.59. The sector median P/E is -1.23. Key valuation ratios for OVID, including P/S (16.86), P/B (2.49), and P/FCF (-2.94), offer insights into how the company is valued relative to its earnings, sales, book value, and free cash flow.

ValuationOVIDSector MedianIndustry AvgS&P 500
P/E (TTM)-3.06-1.23-5.1532.59
P/S (TTM)16.863.71464.725.98
P/B (TTM)2.490.139.085.47
P/FCF (TTM)-2.94-6.89-200.632.07

Frequently Asked Questions

How is OVID price-to-earnings ratio currently?
OVID has a current P/E ratio of -3.06
How are OVID's price-to-sale and price-to-book ratios?
The OVID stock has a trailing twelve month price-to sales (P/S) ratio of 16.86 while its price-to-book (P/B) value is 2.49.
Is Ovid Therapeutics Inc.'s price-to-cashflow ratio high or low?
OVID's price-to-free-cashflow (P/FCF) ratio is -2.94, an indicator that is currently being trending upward.
What's current simple moving average (SMA) for OVID?
Based on OVID's recent bid, its distance from 20 days simple moving average is -0.44%. It is -1.84% apart from 50 days simple moving average, and it is 52.92% apart from 200 days simple moving average.
What is the 52-week price range for OVID?
The 52-week high for OVID is $2.01 which is -20.4% away from the current price level whereas the distance of that from the 52-week low of $0.24 stands at 559.79%.
An overview of OVID's stock performance: how did it fare?
The performance of OVID stock was not encouraging with most of its significant price indicators in red. Ovid Therapeutics Inc.(NASDAQ: OVID) shares have moved upward +10.34% or $0.15 in the latest trading session and have lost -6.75% year-to-date (YTD). The stock has gained nearly 108.22% over the past year. After moving 2.7% over the trailing 3-month period, the stock is 151.07% higher in the 6-month period. Looking at its performance over the shorter term, it'slost -5.59% a week and 2.7% a month.
What is OVID's 14-day relative strength index (RSI)?
The current 14-day RSI for OVID stock is 49.97. Investors and traders alike rely on the relative strength index, or RSI, as an oscillating indicator. In terms of values, the RSI operates within a range ranging from 0 to 100. A rising RSI line indicates strength in the shares. As the RSI line falls, the opposite occurs. It is possible to examine different time periods when using the RSI indicator. Shorter time frames can cause the RSI to be more volatile. Most traders pay close attention to the marks between 30 and 70 on the RSI scale. When the stock price moves over 70, it is often considered to be an indicator of overbought conditions. Dropping below 30 indicates oversold territory. These levels are often used by traders to forecast stock price reversals.
For OVID, what is the average true range (ATR) for the past two weeks?
ATR stands for Average True Range, which may be useful when traders or investors are assessing technical inventory. Currently, Ovid Therapeutics Inc. (OVID) has a 14-day ATR of 0.12.
What is OVID's current enterprise value?
After closing at $1.45 with 71.21M of its shares outstanding, the current enterprise value of OVID is roughly 241.7M.
Over the past year, how has the stock price of OVID changed?
Ovid Therapeutics Inc. (NASDAQ: OVID) is up 108.22% when it comes to the percentage price change over the past 52-weeks. The percentage price change came more than that of broader S&P 500 index that came at a rise of 8.57%. OVID stock price is also down -6.75% on its value in year-to-date trading.
What is the average trading volume for OVID shares?
The number outstanding shares of OVID is 71.21M, and of these 83.71% shares are freely available for trading. On average, OVID stock has traded 1.8M shares per day for the past 10 days. A total of 1.58M shares changed hands during the last trading session with the average session volume of 1.65M shares.
logo

Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.

Stocks Telegraph does not provide any advice or recommendations for buying or selling stocks, securities, or other financial products. Information contained on this website is for informational purposes only and should not be construed as professional financial, investment or other advice. Stocks Telegraph is not liable for any loss or damage that may occur as a result of reliance on this data.

© 2026 Stocks Telegraph All rights reserved.
Most stock quote data provided by Financial Modeling Prep

stockstelegraph

Don't have an account?

stockstelegraph

Don't have an account?

stockstelegraph

Already have an account?

stockstelegraph
Smart Screening Tools for Exceptional Returns
stockstelegraph

For just $1, you can unlock ST Grading’s top-rated stocks that consistently beat the market. Our AI-powered Smart Screener finds winning trades in seconds, helping you uncover hidden opportunities before others do.

Ready to Win Big?

Try Now for Just $1!
stockstelegraph